The author describes several issues in creating drug master files and active substance files for active pharmaceutical ingredients and intermediates. This article covers the submission requirements ...
Become more confident in your daily practices by gaining a deeper understanding of the US and European regulatory requirements for Module 3 (CTD) of your application.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback